Is this U.S.-China selloff a buy? A top Wall Street voice weighs in
Investing.com - Oppenheimer initiated coverage on Hagerty Inc. (NYSE:HGTY) with an Outperform rating and set a price target of $15.00. According to InvestingPro data, the company is currently trading below its Fair Value, with strong momentum reflected in its 33.7% price return over the past six months.
The research firm highlighted that Hagerty is "more than just an auto insurer," noting its specialized focus on classic cars creates a customer base that cares deeply about their vehicles and drives fewer miles than typical auto insurance customers.
Oppenheimer emphasized Hagerty’s multiple revenue streams that function as a "flywheel supporting each other," where insurance customers often become Driver Club members generating subscription revenue, while auctions and private sales boost Marketplace revenue and drive additional insurance sales.
The $15 price target represents a 25.5x multiple on Hagerty’s estimated 2027 earnings per share, derived from a combination of comparable companies including underwriters, high-growth brokers, and subscription/lifestyle businesses with strong brands.
Oppenheimer justified the premium valuation multiple based on Hagerty’s competitive moat, reduced exposure to the property and casualty insurance cycle, and its more diverse revenue streams compared to traditional insurers.
In other recent news, Hagerty Inc. announced its second-quarter earnings for 2025, which showed a mixed performance. The company reported earnings per share of $0.09, falling short of the forecasted $0.11. However, Hagerty surpassed revenue expectations with $369 million, significantly higher than the anticipated $293.87 million. This revenue figure represents a 25.46% surprise over analyst projections. In addition to its earnings report, Hagerty revealed a secondary offering of 8.7 million shares of its Class A Common Stock. The shares are being offered by stockholders Hagerty Holding Corp. and Aldel LLC. These stockholders have also granted underwriters a 30-day option to purchase an additional 1.3 million shares. Notably, Hagerty will not receive any proceeds from this sale.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.